Harmonic Discovery Announces Licensing Agreement with BioVentures and UCSF for FLT3 Mutated AML Development Program
/PRNewswire/ -- Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced...